MYC and breast cancer: These endpoints were then measured in antiestrogen-arrested MCF-7 human breast cancer cells stimulated with E2 in the presence ofsiMyc-17, which reduced the induction of c-Myc protein to less than 2-fold (Fig. 6D, see also Fig. 4).